Legacy Wealth Planning’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$351K Hold
4,073
0.58% 40
2022
Q2
$371K Buy
4,073
+167
+4% +$14.8K 0.53% 42
2022
Q1
$320K Sell
3,906
-141
-3% -$11.1K 0.38% 53
2021
Q4
$310K Sell
4,047
-21
-0.5% -$1.67K 0.35% 58
2021
Q3
$306K Sell
4,068
-200
-5% -$15.2K 0.34% 59
2021
Q2
$332K Sell
4,268
-205
-5% -$15.2K 0.38% 58
2021
Q1
$329K Hold
4,473
0.42% 55
2020
Q4
$349K Sell
4,473
-11
-0.2% -$841 0.45% 48
2020
Q3
$355K Buy
4,484
+798
+22% +$62.5K 0.41% 46
2020
Q2
$272K Sell
3,686
-173
-4% -$13K 0.32% 51
2020
Q1
$283K Hold
3,859
0.45% 46
2019
Q4
$335K Buy
+3,859
New +$317K 0.38% 46

Other funds holding MRK

Legacy Wealth Planning's MRK Position: Q3 2022 in Review

Legacy Wealth Planning held its Merck (MRK) position steady in Q3 2022 at 4,073 shares worth $351K. The position accounts for 0.58% of the portfolio, ranked #40.

Legacy Wealth Planning first reported a position in MRK in Q4 2019 and has held it in 12 quarters since. The position peaked at $371K in Q2 2022. 2,990 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Legacy Wealth Planning held 4,073 shares of Merck worth $351K as of Q3 2022.
  • Legacy Wealth Planning left its Merck share count unchanged in Q3 2022.
  • Merck made up 0.58% of Legacy Wealth Planning's portfolio in Q3 2022, its #40 holding.
  • Legacy Wealth Planning first reported a position in Merck in Q4 2019 and has held it in 12 quarters since.
  • Legacy Wealth Planning's Merck position peaked at $371K in Q2 2022.
  • 2,990 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Legacy Wealth Planning's 13F filing for Q3 2022, filed 10 Nov 2022.